-
公开(公告)号：EP1272457B9
公开(公告)日：2006-12-20
申请号：EP01921087.1
申请日：2001-04-12
IPC分类号： C07C255/34 , C07C255/40 , C07C255/41 , C07C255/42 , A61K31/165
CPC分类号： C07F7/1852 , C07C45/292 , C07C255/41 , C07C255/42 , C07C327/44 , Y02P20/582 , C07C47/277
摘要： Novel styrylacrylonitrile compounds which are useful in treating a variety of cell proliferative disorders such as cancer are disclosed. The compounds are of Formula (I).
-
公开(公告)号：EP1727822A1
公开(公告)日：2006-12-06
申请号：EP05729066.0
申请日：2005-03-22
发明人： ROIFMAN, Chaim M , DEMIN, Peter , FREYWALD, Andrew , GRUNBERGER, Thomas , ROUNOVA, Olga , SHARFE, Nigel
IPC分类号： C07F9/40 , C07C255/29 , C07C255/10 , C07C317/32 , C07D213/40 , C07D317/60 , C07D307/54 , C07F7/02 , A61P35/00 , A61P35/02 , A61K31/277 , A61K31/662 , A61K31/36 , A61K31/44 , A61K31/341 , A61K31/695 , C07C255/14 , C07C255/13 , C07C255/34
CPC分类号： C07C255/41 , C07C255/42 , C07C317/46 , C07C327/44 , C07D213/40 , C07D307/52 , C07D317/58 , C07D317/60 , C07F7/1852 , C07F9/3826 , C07F9/4015
摘要： Novel styrylacrylonitrile compounds which are useful in treating a variety of cell proliferative disorders such as cancer are disclosed.
-
公开(公告)号：EP1272457B1
公开(公告)日：2006-08-23
申请号：EP01921087.1
申请日：2001-04-12
IPC分类号： C07C255/34 , C07C255/40 , C07C255/41 , C07C255/42 , A61K31/165
CPC分类号： C07F7/1852 , C07C45/292 , C07C255/41 , C07C255/42 , C07C327/44 , Y02P20/582 , C07C47/277
摘要： Novel styrylacrylonitrile compounds which are useful in treating a variety of cell proliferative disorders such as cancer are disclosed. The compounds are of Formula (I).
摘要翻译： 公开了用于治疗多种细胞增殖性疾病如癌症的新颖苯乙烯丙烯腈化合物。 该化合物是式（I）的化合物。
-
公开(公告)号：EP1272457A2
公开(公告)日：2003-01-08
申请号：EP01921087.1
申请日：2001-04-12
IPC分类号： C07C255/34 , C07C255/40 , C07C255/41 , C07C255/42 , A61K31/165
CPC分类号： C07F7/1852 , C07C45/292 , C07C255/41 , C07C255/42 , C07C327/44 , Y02P20/582 , C07C47/277
摘要： Novel styrylacrylonitrile compounds which are useful in treating a variety of cell proliferative disorders such as cancer are disclosed. The compounds are of Formula (I).
-
-
-
搜索结果
4 条记录 (耗时 0.016 秒)
